Speakers: David Brown (MHRA), David Wright (AstraZeneca), Simon Day (CTCT Ltd), Michael O’Kelly (IQVIA), Daniel Bratton (GSK), James Roger (Ind) and Mouna Akacha (Novartis).

Incomplete datasets due to missing data is an issue that has been, and will be, around for a long time. At this meeting we will present the evolution of missing data approaches, looking at how they have been handled in the past, the current established missing data approaches and the impact of the new ICH E9 R1 addendum on the handling of missing data, focussing in particular on the treatment policy estimand.

Registration:
PSI Member: £40+VAT 
Non-Member: £135+VAT (price includes PSI membership for the remainder of 2020)
Please click here to register.

Please click here to view the agenda for this event.